1,893
Views
0
CrossRef citations to date
0
Altmetric
Pneumococcal – Research Paper

Health and economic burden associated with 15-valent pneumococcal conjugate vaccine serotypes in Korea and Hong Kong

, , , , &
Article: 2046433 | Received 20 Sep 2021, Accepted 22 Feb 2022, Published online: 14 Apr 2022

References

  • Tan TQ. Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines. Clin Microbiol Rev. 2012 Jul;25(3):409–7. doi:10.1128/CMR.00018-12.
  • Scelfo C, Menzella F, Fontana M, Ghidoni G, Galeone C, Facciolongo NC. Pneumonia and invasive pneumococcal diseases: the role of pneumococcal conjugate vaccine in the era of multi-drug resistance. Vaccines (Basel). 2021 Apr 22;9(5). doi:10.3390/vaccines9050420.
  • Wahl B, O’-Brien KL, Greenbaum A, et al. Burden of streptococcus pneumoniae and haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15. Lancet Glob Health. 2018 Jul;6(7):e744–e757. doi:10.1016/S2214-109X(18)30247-X.
  • Lin TY, Shah NK, Brooks D, Garcia CS. Summary of invasive pneumococcal disease burden among children in the Asia-Pacific region. Vaccine. 2009 Dec 9 ;28(48):7589–605. doi:10.1016/j.vaccine.2010.07.053.
  • Bravo LC. Overview of the disease burden of invasive pneumococcal disease in Asia. Vaccine. 2010 Nov 10 ;27(52):7282–91. doi:10.1016/j.vaccine.2009.04.046.
  • Ho PL, Chiu SS, Cheung CH, Lee R, Tsai TF, Lau YL. Invasive pneumococcal disease burden in Hong Kong children. Pediatr Infect Dis J. 2006 May;25(5):454–55. doi:10.1097/01.inf.0000215004.85582.30.
  • Hon KL, Luk MP, Fung WM, et al. Mortality, length of stay, bloodstream and respiratory viral infections in a pediatric intensive care unit. J Crit Care. 2017 Apr;38:57–61. doi:10.1016/j.jcrc.2016.09.019.
  • Hon KL, Chan KH, Ko PL, Cheung MHY, Tsang KYC, Chan LCN, Chan RWY, Leung TF, Ip M, et al. Change in pneumococcus serotypes but not mortality or morbidity in pre- and post-13-valent polysaccharide conjugate vaccine era: epidemiology in a pediatric intensive care unit over 10 years. J Trop Pediatr. 2018 Oct 1 ;64(5):403–08. doi:10.1093/tropej/fmx084.
  • Hausdorff WP, Feikin DR, Klugman KP. Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis. 2005 Feb;5(2):83–93. doi:10.1016/S1473-3099(05)70083-9.
  • Song JY, Nahm MH, Moseley MA. Clinical implications of pneumococcal serotypes: invasive disease potential, clinical presentations, and antibiotic resistance. J Korean Med Sci. 2013 Jan;28(1):4–15. doi:10.3346/jkms.2013.28.1.4.
  • Hausdorff WP, Hanage WP. Interim results of an ecological experiment - conjugate vaccination against the pneumococcus and serotype replacement. Hum Vaccin Immunother. 2016;12(2):358–74. doi:10.1080/21645515.2015.1118593.
  • Chan KC, Subramanian R, Chong P, Nelson EAS, Lam HS, Li AM, Ip M, et al. Pneumococcal carriage in young children after introduction of PCV13 in Hong Kong. Vaccine. 2016 Jul 19;34(33):3867–74. doi:10.1016/j.vaccine.2016.05.047.
  • Lee JK, Yun KW, Choi EH, Kim SJ, Lee SY, Lee HJ. Changes in the serotype distribution among antibiotic resistant carriage streptococcus pneumoniae isolates in children after the introduction of the extended-valency pneumococcal conjugate vaccine. J Korean Med Sci. 2017 Sep;32(9):1431–39. doi:10.3346/jkms.2017.32.9.1431.
  • Ahn JG, Choi SY, Kim DS, Kim KH. Changes in pneumococcal nasopharyngeal colonization among children with respiratory tract infections before and after use of the two new extended-valency pneumococcal conjugated vaccines. Infect Dis (Lond). 2015 Jun;47(6):385–92. doi:10.3109/00365548.2014.1001997.
  • Choe YJ, Lee HJ, Lee H, et al. Emergence of antibiotic-resistant non-vaccine serotype pneumococci in nasopharyngeal carriage in children after the use of extended-valency pneumococcal conjugate vaccines in Korea. Vaccine. 2016 Sep 14 ;34(40):4771–76. doi:10.1016/j.vaccine.2016.08.030.
  • Balsells E, Guillot L, Nair H, Kyaw MH, Borrow R. Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis. PLoS One. 2017;12(5):e0177113. doi:10.1371/journal.pone.0177113.
  • Ho PL, Law PY, Chiu SS. Increase in incidence of invasive pneumococcal disease caused by serotype 3 in children eight years after the introduction of the pneumococcal conjugate vaccine in Hong Kong. Hum Vaccin Immunother. 2019;15(2):455–58. doi:10.1080/21645515.2018.1526555.
  • Lo SW, Gladstone RA, van Tonder AJ,et al. Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: An international whole-genome sequencing study. Lancet Infect Dis. 2019 Jul;19(7):759–769.
  • Rubin JL, McGarry LJ, Strutton DR, Klugman KP, Pelton SI, Gilmore KE, Weinstein MC, et al. Public health and economic impact of the 13-valent pneumococcal conjugate vaccine (PCV13) in the United States. Vaccine. 2010 Nov 10 ;28(48):7634–43. doi:10.1016/j.vaccine.2010.09.049.
  • Korean Statistical Information Service. Population. 2018 [ accessed 2021 Jul 12]. https://kosis.kr/index/index.do
  • Hong Kong Census and Statistics Department. Population Estimates; [ accessed 2021 Jul 12]. https://www.censtatd.gov.hk/en/web_table.html?id=1A
  • Lee S, Bae S, Lee KJ, Yu JY, Kang Y. Changes in serotype prevalence and antimicrobial resistance among invasive Streptococcus pneumoniae isolates in Korea, 1996–2008. J Med Microbiol. 2013 Aug;62(8):1204–10. doi:10.1099/jmm.0.058164-0.
  • Cho EY, Choi EH, Kang JH, et al. Early Changes in the Serotype Distribution of Invasive Pneumococcal Isolates from Children after the Introduction of Extended-valent Pneumococcal Conjugate Vaccines in Korea, 2011-2013. J Korean Med Sci. 2016 Jul;31(7):1082–88. doi:10.3346/jkms.2016.31.7.1082.
  • Korea Disease Control and Prevention Agency. Serotypes of Pneumococci Isolated from Invasive Infections of Korean Children (2 Year Study); [ accessed 2021 Aug 13]. https://www.prism.go.kr/homepage/
  • Zhang XH, Leeuwenkamp O, Oh KB, Lee YE, Kim CM. Cost-Effectiveness analysis of infant pneumococcal vaccination with PHiD-CV in Korea. Hum Vaccin Immunother. 2018 Jan 2 ;14(1):85–94. doi:10.1080/21645515.2017.1362513.
  • Ho PL, Chiu SS, Ang I, Lau YL. Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae before and after introduction of 7-valent pneumococcal conjugate vaccine, Hong Kong, 1995-2009. Vaccine. 2011 Apr 12;29(17):3270–75. doi:10.1016/j.vaccine.2011.02.025.
  • Hong Kong Centre for Health Protection. Scientific Committee on Vaccine Preventable Diseases. Updated Recommendations on the Use of 13-valent Pneumococcal Conjugate Vaccine in Childhood Immunisation Programme; [ accessed 2021 Jul 14]. https://www.chp.gov.hk/files/pdf/updated_recommendation_on_the_use_of_pcv3_in_hkcip_march2019_accessibility.pdf
  • Lee KK, Rinaldi F, Chan MK, Chan STH, So TMT, Hon EKL, Lee VWY, et al. Economic evaluation of universal infant vaccination with 7vpcv in Hong Kong. Value in Health. 2009 Nov-Dec;12(Suppl 3):S42–48. doi:10.1111/j.1524-4733.2009.00626.x.
  • Wu DB, Roberts C, Lee VW, Hong L-W, Tan KK, Mak V, Lee KKC, et al. Cost-Effectiveness analysis of infant universal routine pneumococcal vaccination in Malaysia and Hong Kong. Hum Vaccin Immunother. 2016;12(2):403–16. doi:10.1080/21645515.2015.1067351.
  • Myers AL, Hall M, Williams DJ, Auger K, Tieder JS, Statile A, Jerardi K, McClain L, Shah SS, et al. Prevalence of bacteremia in hospitalized pediatric patients with community-acquired pneumonia. Pediatr Infect Dis J. 2013 Jul;32(7):736–40. doi:10.1097/INF.0b013e318290bf63.
  • Olarte L, Barson WJ, Barson RM, et al. Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in US Children. Clin Infect Dis. 2015 Sep1;61(5):767–75. doi:10.1093/cid/civ368.
  • Heath Insurance Review and Assessment Service. Guidelines for Economic Assessment of Drugs; [ accessed 2021 Aug 17]. https://repository.hira.or.kr/handle/2019.oak/2541
  • Chan TS, Cheng SS, Chen WT, Hsu DC, Chau RWY, Kang SH, Alsumali A, Kwong Y-L, et al. Cost-Effectiveness of letermovir as cytomegalovirus prophylaxis in adult recipients of allogeneic hematopoietic stem cell transplantation in Hong Kong. J Med Econ. 2020 Dec;23(12):1485–92. doi:10.1080/13696998.2020.1843321.
  • Yuen MF, Liu SH, Seto WK, Mak L-Y, Corman SL, Hsu DC, Lee MYK, Khan TK, Puenpatom A, et al. Cost–utility of All-Oral Direct-Acting Antiviral Regimens for the Treatment of Genotype 1 Chronic Hepatitis C Virus-Infected Patients in Hong Kong. Dig Dis Sci. 2021 Apr;66(4):1315–26. doi:10.1007/s10620-020-06281-8.
  • Census and Statistics Department, Government of the Hong Kong Special Administrative Region. Consumer Prices; [ accessed 2021 Aug 13]. https://www.censtatd.gov.hk/en/scode270.html#section4
  • Federal Reserve Economic Data. Consumer Price Index for All Urban Consumers: Medical Care in U.S. City Average; [ accessed 2021 Aug 13]. https://fred.stlouisfed.org/series/CPIMEDSL
  • World Currency Exchange Rates and Currency Exchange Rate History; [ accessed 2021 Aug 13]. https://www.exchange-rates.org/Rate/KRW/USD/12-31-2018
  • Internal Revenue Service. Yearly Average Currency Exchange Rates; [ accessed 2021 Aug 13]. https://www.irs.gov/individuals/international-taxpayers/yearly-average-currency-exchange-rates
  • Johnson HL, Deloria-Knoll M, Levine OS, Stoszek SK, Freimanis Hance L, Reithinger R, Muenz LR, O'Brien KL, et al. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med. 2010 Oct 5;7(10):e1000348. doi:10.1371/journal.pmed.1000348.
  • Choe YJ, Choi EH, Lee HJ. The changing epidemiology of childhood pneumococcal disease in Korea. Infect Chemother. 2013 Jul;45(2):145–58. doi:10.3947/ic.2013.45.2.145.
  • Pilishvili TPCV13 effects on disease caused by serotype 3. Presentation to the Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention, Atlanta, Georgia;. 2019 Feb 28;Atlanta, Georgia: Advisory Committee on Immunization Practices; [accessed 2021 Jun 9]. https://www.cdc. gov/vaccines/acip/meetings/downloads/min-archive/min-2019- 02-508.pdf
  • European Centre for Disease Prevention and Control. Surveillance atlas of infectious diseases; [ accessed 2021 Jun 9]. https://ecdc.europa.eu/en/surveillance-atlas-infectious-diseases
  • Ladhani SN, Collins S, Djennad A, Sheppard CL, Borrow R, Fry NK, Andrews NJ, Miller E, Ramsay ME, et al. Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study. Lancet Infect Dis. 2018 Apr;18(4):441–51. doi:10.1016/S1473-3099(18)30052-5.
  • Varghese J, Chochua S, Tran T, et al. Multistate population and whole genome sequence-based strain surveillance of invasive pneumococci recovered in the USA during 2017. Clin Microbiol Infect. 2020 Apr;26(4): 512 e510-512 e511. doi:10.1016/j.cmi.2019.09.008.
  • Pilishvili T. PCV13 effects on disease caused by serotype 3. Presentation to the Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention, Atlanta, Georgia; 2019 Feb 28; Atlanta, Georgia: Advisory Committee on Immunization Practices; [accessed 2021 Jun 9]. https://www.cdc.gov/vaccines/acip/meetings/downloads/min-archive/min-2019-02-508.pdf
  • Beall B, Chochua S, Gertz RE Jr., et al. A Population-Based Descriptive Atlas of Invasive Pneumococcal Strains Recovered Within the U.S. During 2015-2016. Front Microbiol. 2018;9:2670. doi:10.3389/fmicb.2018.02670.
  • Kandasamy R, Voysey M, Collins S, et al. Persistent Circulation of Vaccine Serotypes and Serotype Replacement After 5 Years of Infant Immunization with 13-Valent Pneumococcal Conjugate Vaccine in the United Kingdom. J Infect Dis. 2020 Mar 28;221(8):1361–70. doi:10.1093/infdis/jiz178
  • Yeh SH, Gurtman A, Hurley DC, et al. Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlers. Pediatrics. 2010 Sep;126(3):e493–505. doi:10.1542/peds.2009-3027.
  • Kwambana-Adams BA, Mulholland EK, Satzke C, group I. State-of-the-art in the pneumococcal field: Proceedings of the 11(th) International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD-11). Pneumonia (Nathan); Melbourne, Australia. 2020;12:2.
  • Park M, Kim HS, Shin KS, Kim HS, Park JY, Song W, Cho HC, Lee KM, Kim J-S, et al. Changes in the incidence of Streptococcus pneumoniae bacteremia and its serotypes over 10 years in one hospital in South Korea. Vaccine. 2014 Nov 12;32(48):6403–07. doi:10.1016/j.vaccine.2014.09.062.
  • Kim SH, Bae IK, Park D, et al. Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Isolates Causing Invasive and Noninvasive Pneumococcal Diseases in Korea from 2008 to 2014. Biomed Res Int. 2016;2016:6950482.
  • Balsells E, Dagan R, Yildirim I, et al. The relative invasive disease potential of Streptococcus pneumoniae among children after PCV introduction: A systematic review and meta-analysis. J Infect. 2018 Nov;77(5):368–78. doi:10.1016/j.jinf.2018.06.004.
  • Park DC, Kim SH, Yong D, et al. Serotype Distribution and Antimicrobial Resistance of Invasive and Noninvasive Streptococcus pneumoniae Isolates in Korea between 2014 and 2016. Ann Lab Med. 2019 Nov;39(6):537–44. doi:10.3343/alm.2019.39.6.537.
  • Choe YJ, Yang JJ, Park SK, Choi EH, Lee HJ. Comparative estimation of coverage between national immunization program vaccines and non-NIP vaccines in Korea. J Korean Med Sci. 2013 Sep;28(9):1283–88.
  • Sohn S, Hong K, Chun BC. Evaluation of the effectiveness of pneumococcal conjugate vaccine for children in Korea with high vaccine coverage using a propensity score matched national population cohort. Int J Infect Dis. 2020 Apr;93:146–50. doi:10.1016/j.ijid.2020.01.034.
  • Hon KL, Tsang YC, Chan LC, Ng DKK, Miu TY, Chan JY, Lee A, Leung TF, et al. A community-based cross-sectional immunisation survey in parents of primary school students. NPJ Prim Care Respir Med. 2016 Apr 7;26(1):16011. doi:10.1038/npjpcrm.2016.11.
  • Wong CKH, Liao Q, Guo VYW, Xin Y, Lam CLK. Cost-Effectiveness analysis of vaccinations and decision makings on vaccination programmes in Hong Kong: A systematic review. Vaccine. 2017 May 31;35(24):3153–61. doi:10.1016/j.vaccine.2017.04.050.
  • Chan D. Immunisation Coverage for Children Aged Two to Five: Findings of the 2015 Immunisation Survey. Communicable Diseases Watch; [ accessed 2021 Jun 4]. https://www.chp.gov.hk/files/pdf/cdw_v14_6.pdf
  • Yun HE, Ryu BY, Choe YJ. Impact of social distancing on incidence of vaccine-preventable diseases, South Korea. J Med Virol. 2021 Mar;93(3):1814–16. doi:10.1002/jmv.26614.
  • Teng JL, Fok KM, Lin KP, Chan E, Ma Y, Lau SK, Woo PC. Substantial Decline in Invasive Pneumococcal Disease During Coronavirus Disease 2019 Pandemic in Hong Kong. Clinical Infectious Diseases. 2022 Jan 15;74(2):335–8.